project id: TCGA-CESC; case submitter id: TCGA-EK-A3GN; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.84; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.8; rna integrity number: 8.4; age at index: 47; days to birth: -17425; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1958; age at diagnosis: 17425; ajcc pathologic n: NX; ajcc pathologic t: TX; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 27.0; figo stage: Stage IIIB; icd 10 code: C53.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2005; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 2374; initial weight: 90.0; oct embedded: false; preservation method: Unknown; sample id: eb5034e2-d4a7-48e0-9524-31ddd63c9d94; sample submitter id: TCGA-EK-A3GN-01A; portion id: fe64f27e-b1a9-4473-83fb-03515444133f; portion submitter id: TCGA-EK-A3GN-01A-11; slide id: 6f36a1a7-a8d7-434d-ac14-7aac3ce45f59; slide submitter id: TCGA-EK-A3GN-01A-01-TS1; percent lymphocyte infiltration: 10.0; percent monocyte infiltration: 1.0; percent necrosis: 5.0; percent neutrophil infiltration: 0.0; percent normal cells: 30.0; percent stromal cells: 25.0; percent tumor cells: 40.0; percent tumor nuclei: 60.0; section location: TOP;